Announcements Trials
Browse Landscape

Phase

Phase 2 91Phase 3 34Phase 1 15Phase 1/2 11Phase 2/3 4Phase 4 3Phase NA 2Phase EARLY_PHASE1 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Thoracic Neoplasms 1Primary Breast Cancer 1Patient Acceptance of Health Care 1Non-small Cell Lung Cancer Metastatic 1Lung Neoplasms 1Lung Diseases 1

Interventions

Letrozole 20Docetaxel 16Cyclophosphamide 13Zoledronic Acid 12exemestane 11Trastuzumab 11Anastrozole 11Paclitaxel 10Tamoxifen 9Capecitabine 9Fulvestrant 8Epirubicin 8pegfilgrastim 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Saline Solution 6palbociclib 5Sodium Chloride 5Dexmedetomidine 5Carboplatin 5Bupivacaine 5Bevacizumab 5ribociclib 4pegylated granulocyte colony-stimulating factor 4eribulin 4Tranexamic Acid 4Standard of Care 4Pamidronate 4Filgrastim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Vinorelbine × Clear all
NCT03355157 2024-10-01

PADMA

GBG Forschungs GmbH

Phase 4 Completed
130 enrolled
Breast

Breast Neoplasms, Patient Acceptance of Health Care

NCT05131841 2021-11-23

Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC

Zhejiang Cancer Hospital

Phase 4 Unknown
60 enrolled
Breast

Breast Neoplasms

NCT00372476 2017-02-07

INV181

Novartis

Phase 4 Completed
33 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡